STOCKS | Hong Kong Biopharmaceutical Stocks Rise as WuXi AppTec Leads Gains

Hong Kong's biopharmaceutical sector experienced a notable uptick, with WuXi AppTec (02268.HK) leading the charge with an increase of over 7%. According to Jin10, other stocks in the sector, including Rongchang Bio (09995.HK), Junshi Biosciences (01877.HK), InnoCare Pharma (09969.HK), and WuXi Biologics (02359.HK), also saw gains. This upward trend highlights growing investor confidence in the biopharmaceutical industry within the Hong Kong market.